Live feed08:00:00·8dPRReleasevia QuantisnowHumacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual MeetingByQuantisnow·Wall Street's wire, on your screen.HUMA· Humacyte Inc.Health Care
